Subunit vaccine against respiratory syncytial virus infection
US7368537B2 · kind B2 · utility
13Cited by
8References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 9, 2004 |
| Grant date | May 6, 2008 |
| Priority date | — |
| Expiry date | Sep 13, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/18534
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates generally to methods of treating or preventing RSV infections, and more specifically, to compositions, and the use thereof, comprising one or more RSV G protein immunogen or fragment thereof capable of eliciting protective immunity without eliciting an immunopathological response or eliciting a reduced immunopathological response.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.